紫杉醇
透明质酸
体内
胶囊
化学
壳聚糖
淀粉
控制释放
药理学
化疗
有机化学
医学
外科
植物
生物技术
生物
解剖
作者
Beibei Zhao,Zhengbiao Gu,Li Cheng,Yan Hong
出处
期刊:ACS applied polymer materials
[American Chemical Society]
日期:2023-09-21
卷期号:5 (10): 8618-8630
标识
DOI:10.1021/acsapm.3c01751
摘要
Oral delivery of chemotherapeutic drugs has the potential to revolutionize intestinal tumor care, since it is regarded as a noninvasive therapeutic approach that can reduce systemic toxicity and prevent frequent injection. An oral carrier was chitosan-coated porous starch, which was coupled with hyaluronic acid through both sodium trimetaphosphate-mediated cross-linking reaction and hydrogen bonding. Hyaluronic acid cross-linked porous starch (HPS) provides more −OH active sites for nucleation and enrichment of paclitaxel (PTX) in pores; PTX was bound through hydrogen bonds to form a monolayer in porous starch, causing PTX to fill pores by π–π stacking with each other. The targeting of PTX release and tumor inhibitory effects of PTX/HPS coated with chitosan both in vitro and in vivo were demonstrated to be an effective strategy for colonic adenoma therapy. The encapsulated modified porous starch is universal and opens up a pathway for the adsorption and targeted release of chemotherapeutic drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI